Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07213817) titled 'A Study to Assess the Safety, Tolerability, Pharmacokinetic, Pharmacodynamic, Immunogenicity and Antitumour Activity of IPN60300 in Adults With Locally Advanced or Metastatic Solid Tumours' on Oct. 1.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Sequential Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Ipsen
Condition:
Locally Advanced Solid Tumor
Metastatic Solid Tumor
Intervention:
Biological: IPN60300
Recruitment Status: Not recruiting
Phase: Phase 1/Phase 2
Date of First Enrollment: October 30, 2025
Target Sample Size: 102 ...